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Objective: Expression of embryonic myosin heavy chain isoforms and vascular cell
adhesion molecule-1 by neointimal vascular smooth muscle cells are independent
indicators of atherosclerotic plaque development in both human beings and experi-
mental animal models. We examined the chronologic change in smooth muscle cell
myosin heavy chain isoforms, vascular cell adhesion molecule-1 expression, and
mononuclear cell infiltration in a carotid arterial transplant model to ascertain
whether similar phenotypic changes would occur in transplant arteriopathy. 
Methods: Transplanted rabbit carotid arteries were examined at 7, 14, 21, and 35
days (n = 5, 7, 6, and 5, respectively). Lesion progression and the prevalence of
smooth muscle cell myosin heavy chain isoforms, T-lymphocytes, macrophages,
and vascular cell adhesion molecule-1 expression were evaluated immunohisto-
chemically by computerized image analysis. 
Results: In this carotid arterial transplant model, the intima/media area ratio
increased significantly by 35 days (P = .01) as cell density decreased (P = .01), sug-
gesting extracellular matrix elaboration. Intimal smooth muscle cells expressing
embryonic phenotypes were seen as early as 7 days, a phenotypic change that pre-
dated mononuclear cell infiltration of the graft by at least 7 days. By 35 days, up to
70% of intimal smooth muscle cells expressed the embryonic phenotype, coincid-
ing with the transition from inflammatory to chronic lesions. Although, in early
lesions, vascular cell adhesion molecule-1 was identified on luminal endothelium
overlying mononuclear infiltrates, in advanced lesions vascular cell adhesion mole-
cule-1 was identified primarily on intimal vascular smooth muscle cells.
Conclusions: Overall, these vascular smooth muscle cell changes mark important
early events in transplant arteriopathy that may not be ameliorated by immunosup-
pressive regimens in routine use. 
Post-transplant coronary arteriopathy remains the major unsolved prob-lem limiting long-term survival after heart transplantation. Currentroutine post-transplant immunosuppression, directed at host alloim-mune reactivity, may offer little to reduce the smooth muscle cell(SMC) proliferation that characterizes post-transplant arteriopathy.Understanding the transformation that vascular SMCs undergo during
the development of these proliferative intimal lesions is necessary for rational drug
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development for this lethal problem. In nontransplant ather-
osclerosis, expression of vascular cell adhesion molecule
(VCAM-1) on endothelium and on neointimal SMCs is
related to plaque development both in rabbit models1,2 and
in human coronary disease.3,4 We hypothesized that
VCAM-1, as an adhesion molecule specific for mononu-
clear cells, should play an equally important role in the
developing lesions of transplant arteriopathy, theorizing that
immune arteriopathy would be regulated through mononu-
clear cells. We tested this hypothesis in a rabbit model of
carotid arterial allotransplantation.
In addition to VCAM-1 expression, the appearance of
an embryonic or fetal myosin heavy chain isoform has
been reported to be a molecular marker specific for neoin-
timal lesion development in nontransplant atherosclero-
sis.5-8 Among the myosin heavy chain isoforms, the SM1
isoform is the universally present phenotype, present at all
developmental stages, and SM2 is the common adult phe-
notype, seen only postnatally in normal vascular
SMCs.9,10 Both phenotypes are alternative RNA splicing
products that originate from a single gene, regulated
developmentally.5,6 An embryonic isoform, SMemb, or
nonmuscle myosin heavy chain B, is a fetal or embryonic
phenotype that has been found, to date, in human beings
predominantly in fetal life, and, in adults, in ductus arte-
riosus remnants and, pertinently, in the neointimal lesions
of nontransplant atherosclerotic plaques.8,11 All of these
human myosin heavy chain isoforms share more than 90%
homology with their counterparts in the rabbit.8 In rabbit
tissue specimens, similar heterogeneity in myosin heavy
chain isoforms has been reported under designated patho-
logic conditions in vivo, such as restenosis after balloon
injury12-14 and in diet-induced atheromata.7,15-17 In non-
transplant arterial disease, such phenotypic alterations
appear to herald neointimal formation.12,16-18 These
experiments investigate whether similar phenotypic mod-
ulation in SMCs would occur in transplant arteriopathy
and whether such a change would have the same implica-
tions for disease progression. 
Methods
Animals and Experimental Procedures 
SMC transformation was investigated in a new rabbit model of
transplant arteriopathy, an orthotopic carotid arterial transplant
model between two outbred strains of rabbits: New Zealand White
donors and Stauffland recipient rabbits. Carotid arterial grafts were
used rather than venous interposition grafts to avoid the disparities
in vascular wall thickness, distensibility, and myosin heavy chain
composition between arteries and veins.14,19 Rabbits were used
because their arterial disease closely replicates human disease20,21
and because immune recognition sites in the rabbit have close par-
allels to the human histocompatibility loci.22 No immunosuppres-
sion was used to eliminate confounding pharmacologic variables. 
Donor New Zealand White rabbits (mean weight 1.9 kg)
were anesthetized with a mixture of ketamine (35 mg/kg),
xylazine (7 mg/kg), and atropine (0.05 mg/kg), given intramus-
cularly, and then intubated and mechanically ventilated with
Figure 1. A, Intimal lesion development (intima/media area ratio). The intima/media (I/M) area ratio was signifi-
cantly different between specimens at 14 days and those at later time points. Error bars denote the standard devi-
ations. *Multiple comparison P = .01 versus 14 days. B, Cell density was measured as the total number of intimal
cells divided by the total intimal area. There was a significant decrease in cell density between specimens at 14
days and those at later time points, suggesting extracellular matrix production at the later time points. Error bars
denote the standard deviations. *Multiple comparison P = .01 versus 14 days.
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100% oxygen and halothane. After systemic heparinization (500
U/kg), both carotid arteries were harvested from the donor rab-
bit, followed by euthanasia with pentobarbital infusion. Each
donor rabbit provided grafts for two recipient rabbits. Donor
carotid grafts were immersed in cold Ringer’s lactate solution
until implantation. Recipient Stauffland rabbits (mean weight
1.8 kg) were similarly anesthetized and the left carotid arteries
surgically exposed. After intravenous heparinization (250 U/kg),
the common carotid artery was isolated between two atraumatic
vascular clamps and excised. The harvested donor carotid arter-
ial graft was interposed orthotopically between the divided ends
of the recipient carotid, with interrupted 8-0 Prolene sutures
(Ethicon, Inc, Somerville, NJ) being used for the anastomoses.
Graft warm ischemic time was approximately 20 minutes for the
implantation procedure, although total (warm plus cold)
ischemic times for the grafts varied between 30 minutes and 70
minutes because the two recipient operations using the two
carotids from a single donor were performed sequentially. Pairs
of recipient rabbits, one with a shorter and one a longer ischemic
time, were randomized to different protocol groups to ensure
equal representation of shorter and longer ischemic times among
the four groups. 
Recipient rabbits were anesthetized, heparinized, and eutha-
nized for carotid excision on postoperative days 7 (group 1, n = 5),
14 (group 2, n = 7), 21 (group 3, n = 6), and 35 (group 4, n = 5).
In each rabbit, both the transplanted left carotid artery and the
untransplanted native right carotid artery were harvested. The
untransplanted contralateral native carotid artery was used to pro-
vide an internal control since these native carotid arteries in the
transplant recipient animal were exposed to the same circulating
cytokines as the transplanted carotid arteries.
Another set of rabbits underwent sham operations to provide
further controls for the effects of surgical manipulation and
ischemia without transplantation. Sham-operated carotids were
harvested at the same time points (n = 2 at 7, 14, 21, and 35 days).
In the sham operations, the recipient carotid artery was similarly
dissected free from connective tissue and clamped for an ischemic
time equal to the average ischemic time of transplanted grafts.
During the ischemic time, sham-operated arteries were nearly
totally transected and then resutured (essentially an autotransplant)
to expose these carotids to the same surgical trauma and ischemic
times as the transplanted carotid arteries. 
All experiments were performed in accordance with the
“Principles of Laboratory Animal Care,” formulated by the
National Society for Medical Research, and the “Guide for the
Care and Use of Laboratory Animals,” prepared by the Institute of
Laboratory Animal Resources and published by the National
Research Council (National Academy of Sciences, revised 1996). 
Figure 2. Lesion progression in transplanted rabbit carotid arteries: Selected representative specimens at differ-
ent time points after transplantation. The arrowheads mark the internal elastic lamina in all specimens.
(Hematoxylin/eosin stain; magnification bar = 50 µm.) A, Seven days: Minimal lesion is present; single cells are
seen above the internal elastic lamina. B, Fourteen days: The lesion is now several layers deep and a few
mononuclear cells are seen. C, Twenty-one days: An extensive mononuclear infiltrate is evident, with scattered
mononuclear cells in the media. D, Thirty-five days: An example of a late specimen in which the character of the
lesion has changed toward a chronic appearance. A preponderance of SMCs with large nuclei and spindle-
shaped cytoplasm is seen. The density of cells is notably less, suggesting extracellular matrix production. 
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Quantitation of Myosin Isoforms, VCAM-1 Expression,
and Mononuclear Infiltrates 
On immunohistochemistry, the areas within the intima and media
staining positively with antibodies specific for rabbit VCAM-1, T-
lymphocytes, macrophages, and the three SMC heavy chain iso-
forms were defined by computerized image analysis. Mouse
immunoglobulin was used as the control for nonspecific antibody
binding on serial sections run in parallel. Appropriate adjustment
of the gating threshold was necessary to control for variations in
staining intensity between specimens. In some specimens, stained
cells were counted manually on an RGB image monitor at ×400
magnification. For the myosin heavy chain isoforms SM2 and
SMemb, the immunoreactive area defined by SM1 staining was
used as the denominator to determine the ratio of each phenotype
compared with the total SMC (SM1-expressing) area. 
Statistical Methods
Group mean values were compared by 1-way analysis of variance
with P values adjusted for multiple comparisons by the Student-
Newman-Keuls method. When necessary, a log transformation was
applied to the data to stabilize variances. All statistical analyses
were done on a personal computer with SPSS for Windows version
9 statistical software (SPSS, Inc, Chicago, Ill).
Results
Lesion Progression in this Model of Orthotopic Carotid
Allograft Arteriopathy
Intima/media area ratio. Intimal lesion development
accelerated with time (Figure 1, A). In our preliminary work
in this model, an intimal lesion developed in transplanted
carotid arteries of untreated recipient rabbits by 21 days. In
this study, we extended the time points to examine speci-
mens out to 35 days as well to document the transition into
a chronic lesion that closely resembles proliferative human
transplant arteriopathy (Figure 2). There was a significant
Tissue Preparation 
Carotid artery specimens were sectioned transversely and fixed
immediately. Zinc fixation buffer was used to detect antibody
Rb1/9 to VCAM-1, because this fixative allows discrimination of
cellular morphologic features not possible in frozen sections.23 For
other immunocytochemical studies, specimens were fixed in
methyl Carnoy’s solution (methanol/chloroform/glacial acetic acid
= 60:30:10). All specimens were dehydrated through graded
methanol concentrations and embedded in paraffin. In each block,
two sections at the center of each graft were stained with standard
hematoxylin and eosin and adjacent serial sections were prepared
for immunocytochemical evaluation. 
Immunohistochemistry Methods 
Serial 6-µm cross-sections of paraffin-embedded tissue were used
for immunocytochemistry to identify T-lymphocytes,
macrophages, and expression of both VCAM-1 and vascular SMC
myosin heavy chain isoforms (SM1, SM2, SMemb). Antibodies
included monoclonal antibody (mAb) TIB 188 (American Type
Culture Collection, Rockville, Md) for rabbit T-lymphocytes, mAb
RAM-11 (Dako Co, Carpenteria, Calif) specific for rabbit
macrophages, mAb Rb1/9 (a generous gift from Dr Myron
Cybusky), specific for rabbit VCAM-1,1 and antibodies to SM1,
SM2, and SMemb myosin heavy chain isoforms5 (generous gifts
from Dr Ryozo Nagai).
To control for endogenous peroxidase activity, we preincubat-
ed sections with methanol/peroxide (1:1) and then transferred
them to phosphate-buffered saline solution with 0.5% bovine
serum albumin for 30 minutes. So that VCAM-1 expression could
be visualized, sections were incubated overnight at 4°C in prima-
ry antibody to rabbit VCAM-1 (mAb Rb1/9). For other antibodies,
exposure to primary antibody was conducted at room temperature
for 60 minutes. Sections were then incubated in biotinylated horse
anti-mouse immunoglobulin for 30 minutes and signal-amplified
with the ABC Elite avidin-biotin peroxidase technique (Vector
Laboratories, Burlingame, Calif). The black reaction product was
developed by means of 3,3´ diaminobenzidine with nickel chlo-
ride. Slides were counterstained with methyl green to label nuclei,
then dehydrated and mounted.
Assessment of the Intimal Lesion 
For all assessments, including both intimal lesion calculations and
cell type composition, slides were read in a blinded fashion and
analyses were performed in duplicate as a check on the accuracy
of the results.
The extent of intimal lesion development was quantified by cal-
culating the intima/media area ratio obtained from tracing the
perimeter margins of the intima and media on computerized image
analysis (Optimus, Bothell, Wash). This ratio allows comparisons
to be made between arteries of different diameters, thereby reduc-
ing both individual variations between rabbits and the potential for
vascular spasm as confounding variables.
Intimal cell density was calculated as the total number of
intimal cells divided by the intimal area. The total number of
intimal cells was obtained by counting the number of intimal
nuclei using the same software on specimens stained with hema-
toxylin and eosin.
Figure 3. Time course of T-lymphocyte and macrophage infiltration
into the intima. In these specimens, T-lymphocytes were first seen
at 14 days, and macrophages appeared by 21 days. Error bars
denote the standard deviations of the means. 
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difference in the intima/media area ratio between specimens
at 14 days and those at the two later time points (multiple
comparison P = .01).
Cell density. A significant decrease in cell density was
observed between 14 days and later time points (multiple
comparison P = .01), suggesting a substantial increase in
extracellular matrix production (Figure 1, B). This change in
cell density coincided with the transition from an inflamma-
tory to a chronic, SMC-based lesion (Figure 2, D).
Mononuclear cell infiltration into the intima. T-lympho-
cytes were not detected in either the intima or the media on
the 7-day specimens (Figure 3). At 14 days, occasional and
very localized collections of T-lymphocytes appeared in the
intima (Figure 4), but medial T-lymphocytes were still rare.
By 21 days, T-lymphocytes had become the major compo-
nent of the developing lesion. The appearance of
macrophages in the lesions lagged behind the T-lympho-
cytes, being first detected at 21 days and not becoming
abundant in the developing lesion until 35 days.
Intimal SMCs. SMCs, detected as cells expressing the
SM1 isoform, could be seen in the intima as early as 7 days
in all transplanted grafts. The total number of intimal SMCs
increased with time but accelerated rapidly between 14 and
35 days, coinciding with the change in cellular composition
(Figure 1, Table 1). 
Phenotypic Switch in SMC Heavy Chain Myosin
Isoforms With Neointimal Formation 
Over the 35 days, phenotypic modulation occurred in the
myosin heavy chain isoforms in the SMCs comprising the inti-
mal lesion (Figure 5). The embryonic phenotype, SMemb,
which was not present in vascular SMCs in normal arteries,
could be seen in intimal SMCs as well as in medial SMCs
located just below the internal elastic lamina as early as 7 days
(Figure 5, C). The percentage of SMCs co-expressing SMemb
increased between 14 and 21 days until well over half (70%)
of the neointimal SMCs at 35 days were of the embryonic
phenotype (Figure 5, I, Table 1).
VCAM-1 Expression in Carotid Allografts
Early phase. VCAM-1 expression was occasionally seen
on luminal endothelial cells at 7 days (Figure 6, A).
Interestingly, in the 14-day specimens, endothelial VCAM-
1 expression was often found overlying the area of T-lym-
phocyte infiltration, suggesting that VCAM-1 may be
directly responsible for lymphocyte recruitment into the
lesion at this time point (Figure 6, C and D).
Late phase. By the two later time points, at days 21 and
35, VCAM-1 was identified not only on endothelial cells
but also on intimal SMCs, where its expression appeared to
co-localize with intimal SMC expression of the embryonic
myosin heavy chain phenotype on histologic sections
(Figure 6, E to H).
Sham-Operated Controls 
In contrast to the transplanted carotids, there was no significant
intimal lesion and no mononuclear infiltration in the sham-
operated arteries at 35 days nor in the unoperated native control
arteries (Figure 7). The embryonic SMC phenotype, SMemb,
was not seen in either the 7-day or 35-day sham-operated grafts.
Also, VCAM-1 was not seen, even on endothelium, in either
the 7-day or the 35-day sham-operated grafts. These sham con-
trols demonstrate that surgical manipulation and a relatively
short ischemic time does not, by itself, cause SMC infiltration,
dedifferentiation, or VCAM-1 up-regulation.
Effects of Graft Ischemia 
The effect of carotid graft ischemic time (30 minutes vs 70
minutes) on intimal lesion formation was analyzed sepa-
rately. There was no difference in the extent of lesion or
mononuclear infiltration between the grafts with short ver-
sus longer total ischemic times (data not shown).
Figure 4. Early appearance of mononuclear cells in a 14-day specimen. On all immunocytochemistry specimens,
specific antibodies are visualized by a black reaction product. (Methyl green nuclear counterstain; arrowheads
mark the internal elastic lamina in panels B and C.) A, T-lymphocytes: Although a circumferential lesion has
developed, T-lymphocyte infiltration (in black) is still infrequent and localized (mAb TIB 188; magnification bar =
100 µm). B, T-lymphocytes at higher magnification confined to the intima above the internal elastic lamina (mAb
TIB 188, magnification bar = 50 µm). C, Macrophages: No macrophages are present at 14 days (mAb Ram-11, mag-
nification bar = 50 µm).
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Discussion
We followed neointimal formation in a new model of rabbit
orthotopic carotid arterial allotransplantation to study the
phenotypic transformation of vascular SMCs in transplant
arteriopathy. Importantly, unlike balloon injury models, the
endothelium remains intact in this model. Also validating
this model are the close parallels between lesion develop-
ment in these carotid transplants with the changes seen in
coronary arteries in acute and chronic rejection after cardiac
transplantation.22,24,25 Additionally, the orthotopic position
Figure 5. SMC phenotypes in developing intimal lesions. (Methyl green nuclear counterstain; white and black arrowheads
both mark the internal elastic lamina in different panels.) In each column, cells staining positively with antibody to SM1,
SM2, or Smemb on these immunocytochemistry panels are visualized as black. A to C, Seven-day specimens: A, mAb to
SM1; B, SM2; C, SMemb (embryonic phenotype). A, Although only a few intimal cells are seen at this early stage, SMCs are
already detectable in the intima above the internal elastic lamina (arrow). All intimal SMCs express SM1. B, Some of these
early intimal SMCs also express the SM2 phenotype (arrow). C, The embryonic phenotype, SMemb, is expressed by intimal
SMCs (arrow) as early as 7 days as well as by endothelial cells. Importantly, SMCs just below the internal elastic lamina in
the media also express the embryonic phenotype (double arrow: note dark staining on some SMCs in the media below the
translucent internal elastic lamina; medial SMCs usually express SM1 and SM2 but not SMemb). No mononuclear cells are
present. (Magnification bar = 10 µm). D to F, Fourteen-day specimens: D, SM1; E: SM2; F, SMemb. D, At 14 days, the intimal
lesion above the internal elastic lamina (white arrowheads) is seen to be composed primarily of SMCs, all of which express
SM1. E, Fewer intimal SMCs express SM2 than SM1; all medial SMCs express SM2 as expected. F, Many intimal SMCs
express the embryonic phenotype, SMemb, as well as some medial SMCs just below the internal elastic lamina.
(Magnification bar = 50 µm.) G to I, Thirty-five–day specimens with changes characteristic of chronic lesions: G, SM1; H,
SM2; I, SMemb. Note that the intimal area above the internal elastic lamina (arrowheads) occupies the entire photograph.
G, Intimal SMCs, expressing SM1, have become spindle shaped. H, These intimal SMCs are no longer expressing SM2. I,
The vast majority of intimal SMCs now co-express the embryonic phenotype, SMemb. (Magnification bar = 50 µm.)
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Figure 6. VCAM-1 expression in carotid allografts. In all photographs, the arrowheads mark the internal elastic lami-
na. A, Seven days: VCAM-1 expression (stained in black, mAb Rb1/9, methyl green nuclear counterstain) on occasion-
al endothelial cells (black arrow). Magnification = 50 µm. B to D, Fourteen days: A specimen with a small intimal
lesion. B, Platelet endothelial cell adhesion molecule-1 staining (in black, as an endothelial marker) demonstrating an
intact endothelium; C, VCAM-1 staining (in black, mAb Rb1/9), demonstrating VCAM-1 expression on endothelium; D,
T-lymphocytes are stained black (mAb Tib 188), demonstrating that endothelial VCAM-1 expression is overlying the
area of T-lymphocyte infiltration. Magnification bar = 50 µm. E to H, Thirty-five–day specimen with a large intimal
lesion, comparing the localization of VCAM-1 expression and SM1 expression on the same specimen. Internal elastic
lamina is marked by arrowheads. Note that the intima comprises most of the field. Panels E and G are low magnifica-
tion (magnification bar = 100 µm); panels F and H are the same specimens at higher magnification (magnification bar
= 50 µm). E and F, VCAM-1 expression (in black, mAb Rb1/9). VCAM-1 expression is seen both on endothelium and on
the elongated SMCs throughout the neointima in a pattern consistent with SMC, not leukocyte, expression. Deep in the
neointima, VCAM-1 is also seen in SMCs concentrated just above the internal elastic lamina. G and H, SM1 staining in
black. SM1 expression defining SMCs in the same 35-day specimens. The pattern of SMC expression in the neointimal
SMCs is similar to VCAM-1 expression. Dark SM-1 staining is also seen in the media below the internal elastic lami-
na as expected (all medial SMCs express SM1). 
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of the carotid graft ensures that shear forces will not be
unnaturally distorted. Most pertinent to the clinical situa-
tion, however, is that this model simulates not only the very
beginning of transplant arteriopathy but also the transition
point between early inflammatory lesions and later chronic
lesions composed primarily of SMCs and extracellular
matrix, albeit over a condensed time frame compared with
human transplant arteriopathy.
SMC Infiltration May Precede Mononuclear
Infiltration 
We have shown that early SMC infiltration precedes the
infiltration of both T-lymphocytes and macrophages in this
model of transplant arteriopathy. Early SMC infiltration of
coronary vessels was similarly noted by Kuwahara and
associates21 in rabbit cardiac transplants. These findings not
only differ from our own expectations of the pathogenesis of
an immune-mediated arteriopathy but also differ from the
commonly accepted paradigm for plaque development in
both transplant arteriopathy and nontransplant atherogene-
sis in which infiltrating mononuclear cells are considered as
primary instigators of early lesion development.26-28 In this
carotid transplant model, we can also demonstrate that
medial vascular SMCs just below the internal elastic lamina
begin expressing the embryonic myosin heavy chain pheno-
type up to a week before mononuclear infiltration, a phe-
nomenon also described in neointimal formation in experi-
mental atherosclerosis15,16 and restenosis.13,14 This finding
strongly suggests that endothelial activation alone, with
cytokine or growth factor elaboration and/or signaling
through adjacent SMCs or matrix components, can result in
medial SMC phenotypic modulation even without direct
contact between mononuclear cells and SMCs. In such an
immune-related arteriopathy, endothelial activation is pre-
sumably the result of allogeneic leukocyte engagement of
endothelial surface adhesion receptors, which can initiate
signaling pathways in endothelial cells29 in addition to acti-
vating the circulating T-lymphocytes. 
That surgically induced ischemia alone might have caused
this early intimal SMC infiltration is unlikely because SMC
infiltration was not seen in the sham-operated carotid arteries
that were exposed to the same surgical manipulation and
ischemic times. Additionally, in these experiments, the trans-
planted carotid arteries with the longer ischemic times did not
have more extensive lesions than those with shorter ischemic
times. Nonetheless, without a larger sample size or longer
ischemic times, it is impossible to rule out that exposure to
ischemia might predispose vascular endothelium to subse-
quent activation or injury by immune mechanisms, effects that
could be synergistic.
The question could be raised as to whether these individ-
ual cells below the endothelium at 7 days might represent
adherence of circulating recipient-derived stem cells.
Although recipient origin is certainly a possibility, the fact
that medial SMCs just below the internal elastic lamina are
also seen to express this embryonic isoform suggests that
these medial cells might be phenotypically transformed
cells just before migration into the intima. Alternatively, in
both the intima and the media, the cells expressing the
embryonic phenotype might represent rests of multipotent
cells with the potential for SMC dedifferentiation.13,30
SMC Phenotypic Switch to Embryonic Isoforms
Accelerates With Mononuclear Cell Infiltration 
Even though SMC dedifferentiation into the embryonic phe-
notypes could be seen at all time points, the percentage of
SMCs expressing this abnormal phenotype increased signif-
icantly over time. The rapid increase correlated with the
arrival of mononuclear cells into the lesion and with extra-
cellular matrix elaboration. Interestingly, in this model,
macrophage infiltration was not seen until later in lesion
development. Unlike the key early role ascribed to
macrophages in nontransplant atherosclerosis,26-28 the late
appearance of macrophages in this model suggests that dif-
ferent mechanisms may be operative in transplant versus
nontransplant arteriopathy.
Figure 7. Sham-operated carotid artery specimens stained with antibody to SM1. A, Seven days. B, Thirty-five
days. (Methyl green counterstain, magnification bar = 50 µm). The internal elastic lamina is visualized as a
translucent line (white arrowheads) above the heavily SM1-positive SMCs in the media. There is no detectable
lesion: that is, no intimal SMCs are identified above the internal elastic lamina. 
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VCAM-1 Expression on Endothelium Overlies Areas of
Mononuclear Cell Recruitment 
VCAM-1 was clearly expressed by endothelial cells before
T-lymphocyte infiltration. VCAM-1 expression was also
seen to overlie pockets of leukocyte infiltration composed
solely of lymphocytes, suggesting, as has been shown in
other models, that endothelial VCAM-1 expression is
important in the initial recruitment of mononuclear cells
into the allograft.31-33 In this respect, this function of
endothelial VCAM-1 expression may mimic its purported
early role in human nontransplant atherogenesis.1-3,34
Vascular SMC Expression of VCAM-1 and Embryonic
Myosin Heavy Chain Isoforms May Signify an
Activated Phenotype 
However, both in this model of transplant arteriopathy and in
our previous studies of human atherosclerotic plaques,4 it
may be SMC expression of VCAM-1, more than endothelial
expression, that characterizes the transition to the pathologic
state. In cultured human aortic SMCs, VCAM-1 expression
appears to be uniquely linked to the differentiation process in
SMCs,35,36 and, furthermore, to be under different transcrip-
tional control depending on the stage of differentiation.36
Tumor necrosis factor α–induced expression of VCAM-1
occurs preferentially in undifferentiated SMC populations in
vitro,36 supporting our finding of histologic co-localization
of VCAM-1 expression with these dedifferentiated myosin
phenotypes in transplant arteriopathy. VCAM-1 expression
by SMCs might allow direct interactions with T cells and/or
macrophages deep within intimal lesions, with other SMCs
expressing the VCAM-1 receptor, very late activation-4,35 or
with extracellular matrix ligands.37
The potential import of these phenotypic changes is illus-
trated by previous reports, which found that experimental
atherosclerosis develops only in vessels that contain rests of
SMCs expressing these embryonic phenotypes.17,38 In
human pathologic conditions, this same embryonic pheno-
type (nonmuscle myosin B) has been found in the neointima
in human atherectomy specimens with restenosis, a prolif-
erative arteriopathy with pathologic similarities to trans-
plant arteriopathy.39 If this phenotypic modulation is equiv-
alent to activation of vascular SMCs, then expression of this
phenotype might mark cells destined for subsequent clonal
expansion,30,40 proliferation, migration, and/or extracellular
matrix production.9,41 Most important, it has recently been
shown that strategies that block phenotypic modulation and
encourage persistence of stable adult myosin isoforms may
prevent lesion progression in nontransplant arteriopa-
thy.17,42,43 Defining the cell populations subject to dediffer-
entiation or embryonic rests with potential for clonal expan-
sion and the factors that influence phenotypic modulation
may likewise uncover new therapeutic approaches for trans-
plant arteriopathy. Current immunosuppressive therapies,
directed at leukocytes, may not be effective at preventing the
development of transplant arteriopathy. Instead, therapeutic
strategies targeting SMC activation and dedifferentiation,
and/or early endothelial activation and signaling, may be
necessary for the prevention of transplant arteriopathy. 
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